237 related articles for article (PubMed ID: 16955509)
21. Improved results of surgical treatment for esophageal and gastroesophageal junction carcinomas after preoperative combined chemotherapy and radiation.
MacFarlane SD; Hill LD; Jolly PC; Kozarek RA; Anderson RP
J Thorac Cardiovasc Surg; 1988 Mar; 95(3):415-22. PubMed ID: 3343850
[TBL] [Abstract][Full Text] [Related]
22. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
Zhang X; Watson DI; Jamieson GG
Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
[TBL] [Abstract][Full Text] [Related]
23. Accuracy of pathologic examination in detection of complete response after chemoradiation for esophageal cancer.
Chang EY; Smith CA; Corless CL; Thomas CR; Hunter JG; Jobe BA
Am J Surg; 2007 May; 193(5):614-7; discussion 617. PubMed ID: 17434367
[TBL] [Abstract][Full Text] [Related]
24. Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junction.
Barbour AP; Rizk NP; Gerdes H; Bains MS; Rusch VW; Brennan MF; Coit DG
J Am Coll Surg; 2007 Oct; 205(4):593-601. PubMed ID: 17903735
[TBL] [Abstract][Full Text] [Related]
25. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
Rizzetto C; DeMeester SR; Hagen JA; Peyre CG; Lipham JC; DeMeester TR
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1228-36. PubMed ID: 18544359
[TBL] [Abstract][Full Text] [Related]
26. [Induction treatment of locally advanced operable cancers of the esophagus. Prognostic significance of the histologic response].
Thomas P; Doddoli C; Giacoia A; Garbe L; Perrier H; Giovannini M; Seitz JF; Hannoun-Levi JM; Giudicelli R; Fuentes P
Ann Chir; 1997; 51(3):222-31. PubMed ID: 9297883
[TBL] [Abstract][Full Text] [Related]
27. Surgical pathology stage by American Joint Commission on Cancer criteria predicts patient survival after preoperative chemoradiation for localized gastric carcinoma.
Rohatgi PR; Mansfield PF; Crane CH; Wu TT; Sunder PK; Ross WA; Morris JS; Pisters PW; Feig BW; Gunderson LL; Ajani JA
Cancer; 2006 Oct; 107(7):1475-82. PubMed ID: 16944539
[TBL] [Abstract][Full Text] [Related]
28. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
[TBL] [Abstract][Full Text] [Related]
29. Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancer.
Prenzel KL; König A; Schneider PM; Schnickmann C; Baldus SE; Schröder W; Bollschweiler E; Dienes HP; Mueller RP; Izbicki JR; Hölscher AH
Ann Surg Oncol; 2007 Feb; 14(2):954-9. PubMed ID: 17103071
[TBL] [Abstract][Full Text] [Related]
30. Significance of post-chemoradiation biopsy in predicting residual esophageal carcinoma in the surgical specimen.
Yang Q; Cleary KR; Yao JC; Swisher SG; Roth JA; Lynch PM; Komaki R; Ajani JA; Rashid A; Hamilton SR; Wu TT
Dis Esophagus; 2004; 17(1):38-43. PubMed ID: 15209739
[TBL] [Abstract][Full Text] [Related]
31. Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer.
White RR; Xie HB; Gottfried MR; Czito BG; Hurwitz HI; Morse MA; Blobe GC; Paulson EK; Baillie J; Branch MS; Jowell PS; Clary BM; Pappas TN; Tyler DS
Ann Surg Oncol; 2005 Mar; 12(3):214-21. PubMed ID: 15827813
[TBL] [Abstract][Full Text] [Related]
32. Clinical impact of endoscopic submucosal dissection for superficial adenocarcinoma located at the esophagogastric junction.
Yoshinaga S; Gotoda T; Kusano C; Oda I; Nakamura K; Takayanagi R
Gastrointest Endosc; 2008 Feb; 67(2):202-9. PubMed ID: 18226681
[TBL] [Abstract][Full Text] [Related]
33. Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial.
Le Scodan R; Mornex F; Partensky C; Mercier C; Valette PJ; Ychou M; Roy P; Scoazec JY
Am J Clin Oncol; 2008 Dec; 31(6):545-52. PubMed ID: 19060585
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of proliferation activity and neuroendocrine differentiation to predict treatment failure after radical prostatectomy.
May M; Siegsmund M; Hammermann F; Loy V; Gunia S
Scand J Urol Nephrol; 2007; 41(5):375-81. PubMed ID: 17853019
[TBL] [Abstract][Full Text] [Related]
35. The impact of preoperative radiochemotherapy on survival in advanced esophagogastric junction signet ring cell adenocarcinoma.
Bekkar S; Gronnier C; Messager M; Robb WB; Piessen G; Mariette C;
Ann Thorac Surg; 2014 Jan; 97(1):303-10. PubMed ID: 24200394
[TBL] [Abstract][Full Text] [Related]
36. The frequency and clinical significance of neuroendocrine cells within stage III adenocarcinomas of the colon.
Foley EF; Gaffey MJ; Frierson HF
Arch Pathol Lab Med; 1998 Oct; 122(10):912-4. PubMed ID: 9786353
[TBL] [Abstract][Full Text] [Related]
37. Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophagogastric junction.
von Rahden BH; Stein HJ; Feith M; Becker K; Siewert JR
J Clin Oncol; 2005 Feb; 23(4):874-9. PubMed ID: 15681533
[TBL] [Abstract][Full Text] [Related]
38. Prospective impact of tumor grade assessment in biopsies on tumor stage and prognostic grouping in gastroesophageal adenocarcinoma: relevance of the seventh edition American Joint Committee on Cancer Staging Manual revision.
Dikken JL; Coit DG; Klimstra DS; Rizk NP; van Grieken N; Ilson D; Tang LH
Cancer; 2012 Jan; 118(2):349-57. PubMed ID: 21720993
[TBL] [Abstract][Full Text] [Related]
39. Neuroendocrine differentiation as an indicator of chemosensitivity and prognosis in nonsmall cell lung cancer.
Petrović M; Baskić D; Banković D; Ilić N
Biomarkers; 2011 Jun; 16(4):311-20. PubMed ID: 21595568
[TBL] [Abstract][Full Text] [Related]
40. The prognostic value of neuroendocrine differentiation in adenocarcinoma of the prostate in relation to progression of disease after endocrine therapy.
Krijnen JL; Bogdanowicz JF; Seldenrijk CA; Mulder PG; van der Kwast TH
J Urol; 1997 Jul; 158(1):171-4. PubMed ID: 9186347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
